The Glycosaminoglycan-binding Domain of PRELP Acts As a Cell Type-specific NF-kappaB Inhibitor That Impairs Osteoclastogenesis

Overview

Journal J Cell Biol

Specialty Cell Biology

Date 2009 Dec 3

PMID 19951916

Citations 30

Authors

Nadia Rucci

Anna Rufo

Marina Alamanou

Mattia Capulli

Andrea Del Fattore

Emma Ahrman

Daria Capece

Valeria Iansante

Francesca Zazzeroni

Edoardo Alesse

Dick Heinegard

Anna Teti

Affiliations

Soon will be listed here.

Abstract

Proline/arginine-rich end leucine-rich repeat protein (PRELP) is a glycosaminoglycan (GAG)- and collagen-binding anchor protein highly expressed in cartilage, basement membranes, and developing bone. We observed that PRELP inhibited in vitro and in vivo mouse osteoclastogenesis through its GAG-binding domain ((hbd)PRELP), involving (a) cell internalization through a chondroitin sulfate- and annexin II-dependent mechanism, (b) nuclear translocation, (c) interaction with p65 nuclear factor kappaB (NF-kappaB) and inhibition of its DNA binding, and (d) impairment of NF-kappaB transcriptional activity and reduction of osteoclast-specific gene expression. (hbd)PRELP does not disrupt the mitogen-activated protein kinase signaling nor does it impair cell survival. (hbd)PRELP activity is cell type specific, given that it is internalized by the RAW264.7 osteoclast-like cell line but fails to affect calvarial osteoblasts, bone marrow macrophages, and epithelial cell lines. In vivo, (hbd)PRELP reduces osteoclast number and activity in ovariectomized mice, underlying its physiological and/or pathological importance in skeletal remodeling.

Citing Articles

Comprehensive investigation of proteoglycan gene expression in breast cancer: Discovery of a unique proteoglycan gene signature linked to the malignant phenotype.

Buraschi S, Pascal G, Liberatore F, Iozzo R Proteoglycan Res. 2025; 3(1).

PMID: 40066261 PMC: 11893098. DOI: 10.1002/pgr2.70014.

ASPORIN: A root of the matter in tumors and their host environment.

Lall S, Alsafwani Z, Batra S, Seshacharyulu P Biochim Biophys Acta Rev Cancer. 2023; 1879(1):189029.

PMID: 38008263 PMC: 10872503. DOI: 10.1016/j.bbcan.2023.189029.

Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma.

Schafer H, Subbarayan K, Massa C, Vaxevanis C, Mueller A, Seliger B J Transl Med. 2023; 21(1):643.

PMID: 37730606 PMC: 10512569. DOI: 10.1186/s12967-023-04476-x.

Chondrocyte Homeostasis and Differentiation: Transcriptional Control and Signaling in Healthy and Osteoarthritic Conditions.

Michelacci Y, Baccarin R, Rodrigues N Life (Basel). 2023; 13(7).

PMID: 37511835 PMC: 10381434. DOI: 10.3390/life13071460.

Ginsenosides from as Key Modulators of NF-κB Signaling Are Powerful Anti-Inflammatory and Anticancer Agents.

Jang W, Hwang J, Cho J Int J Mol Sci. 2023; 24(7).

PMID: 37047092 PMC: 10093821. DOI: 10.3390/ijms24076119.

References

Idris A, Sophocleous A, Landao-Bassonga E, Vant Hof R, Ralston S . Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor. Endocrinology. 2008; 149(11):5619-26. DOI: 10.1210/en.2008-0150. View

Young D, Lakey R, Pennington C, Jones D, Kevorkian L, Edwards D . Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res Ther. 2005; 7(3):R503-12. PMC: 1174946. DOI: 10.1186/ar1702. View

Hennekam R . Hutchinson-Gilford progeria syndrome: review of the phenotype. Am J Med Genet A. 2006; 140(23):2603-24. DOI: 10.1002/ajmg.a.31346. View

Bengtsson E, Aspberg A, Heinegard D, Sommarin Y, Spillmann D . The amino-terminal part of PRELP binds to heparin and heparan sulfate. J Biol Chem. 2000; 275(52):40695-702. DOI: 10.1074/jbc.M007917200. View

Albini A, Iwamoto Y, Kleinman H, Martin G, Aaronson S, Kozlowski J . A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987; 47(12):3239-45. View

Menaa C, Devlin R, Reddy S, Gazitt Y, Choi S, Roodman G . Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures. J Clin Invest. 1999; 103(11):1605-13. PMC: 408373. DOI: 10.1172/JCI6374. View

Parfitt A, Drezner M, Glorieux F, Kanis J, MALLUCHE H, Meunier P . Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987; 2(6):595-610. DOI: 10.1002/jbmr.5650020617. View

Harder T, Kellner R, Parton R, Gruenberg J . Specific release of membrane-bound annexin II and cortical cytoskeletal elements by sequestration of membrane cholesterol. Mol Biol Cell. 1997; 8(3):533-45. PMC: 276102. DOI: 10.1091/mbc.8.3.533. View

Teitelbaum S, Ross F . Genetic regulation of osteoclast development and function. Nat Rev Genet. 2003; 4(8):638-49. DOI: 10.1038/nrg1122. View

10.

Li J, Liao E, Dai R, Wei Q, Luo X . Effects of 17 beta-estradiol on the expression of interstitial collagenases-8 and -13 (MMP-8 and MMP-13) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in ovariectomized rat osteoblastic cells. J Mol Histol. 2004; 35(8-9):723-31. DOI: 10.1007/s10735-004-6206-3. View

11.

Breckon J, Papaioannou S, Kon L, Tumber A, Hembry R, Murphy G . Stromelysin (MMP-3) synthesis is up-regulated in estrogen-deficient mouse osteoblasts in vivo and in vitro. J Bone Miner Res. 1999; 14(11):1880-90. DOI: 10.1359/jbmr.1999.14.11.1880. View

12.

Aguiar D, Knudson W, Knudson C . Internalization of the hyaluronan receptor CD44 by chondrocytes. Exp Cell Res. 1999; 252(2):292-302. DOI: 10.1006/excr.1999.4641. View

13.

Suzuki K, Zhu B, Rittling S, Denhardt D, Goldberg H, McCulloch C . Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts. J Bone Miner Res. 2002; 17(8):1486-97. DOI: 10.1359/jbmr.2002.17.8.1486. View

14.

Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K . Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem. 2000; 276(8):5836-40. DOI: 10.1074/jbc.M007540200. View

15.

Deepa S, Yamada S, Zako M, Goldberger O, Sugahara K . Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors. A novel function to control.... J Biol Chem. 2004; 279(36):37368-76. DOI: 10.1074/jbc.M403031200. View

16.

Nakamura H, Sato G, Hirata A, Yamamoto T . Immunolocalization of matrix metalloproteinase-13 on bone surface under osteoclasts in rat tibia. Bone. 2004; 34(1):48-56. DOI: 10.1016/j.bone.2003.09.001. View

17.

Nakano K, Okada Y, Saito K, Tanaka Y . Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts. Arthritis Rheum. 2004; 50(8):2450-8. DOI: 10.1002/art.20367. View

18.

Majumdar M, Chockalingam P, Bhat R, Sheldon R, Keohan C, Blanchet T . Immortalized mouse articular cartilage cell lines retain chondrocyte phenotype and respond to both anabolic factor BMP-2 and pro-inflammatory factor IL-1. J Cell Physiol. 2007; 215(1):68-76. DOI: 10.1002/jcp.21282. View

19.

Futaki S, Nakase I, Tadokoro A, Takeuchi T, Jones A . Arginine-rich peptides and their internalization mechanisms. Biochem Soc Trans. 2007; 35(Pt 4):784-7. DOI: 10.1042/BST0350784. View

20.

Grover J, Lee E, Mounkes L, Stewart C, Roughley P . The consequence of PRELP overexpression on skin. Matrix Biol. 2006; 26(2):140-3. DOI: 10.1016/j.matbio.2006.10.005. View